Abemaciclib

GPTKB entity

Statements (35)
Predicate Object
gptkbp:instanceOf gptkb:drug
cyclin-dependent kinase inhibitor
gptkbp:approvalYear 2017
gptkbp:approvedBy gptkb:FDA
gptkb:EMA
gptkbp:ATCCode L01EF03
gptkbp:brand gptkb:Verzenio
gptkbp:CASNumber 1231929-97-7
gptkbp:chemicalFormula C27H32F2N8
gptkbp:combines gptkb:fulvestrant
aromatase inhibitors
gptkbp:developer gptkb:Eli_Lilly_and_Company
gptkbp:eliminationHalfLife 18 hours
https://www.w3.org/2000/01/rdf-schema#label Abemaciclib
gptkbp:indication hormone receptor-positive, HER2-negative advanced or metastatic breast cancer
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction inhibits CDK4 and CDK6, blocking cell cycle progression
gptkbp:metabolism liver
gptkbp:molecularWeight 506.6 g/mol
gptkbp:pregnancyCategory not recommended
gptkbp:proteinBinding 96.3%
gptkbp:routeOfAdministration oral
gptkbp:sideEffect nausea
vomiting
diarrhea
abdominal pain
fatigue
infections
neutropenia
gptkbp:target gptkb:CDK4
gptkb:CDK6
gptkbp:usedFor gptkb:cancer
gptkbp:bfsParent gptkb:Cdk4
gptkb:Serine/threonine-protein_kinase_CDK4
gptkbp:bfsLayer 8